# clm_E1A1DD321AA2

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: cash_and_equivalents  
value: 809,102,000 United States dollar  
valid_from: 2015-12-31  
valid_to: 2016-03-31  
published: 2016-02-11  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0DC1B23A3E38  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals cash and equivalents: 809,102,000 United States dollar", as of 2015-12-31 (until 2016-03-31). Claim clm_E1A1DD321AA2, https://asof.is/claim/clm_E1A1DD321AA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-11  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm (primary, SEC EDGAR 10-K FY2015, published 2016-02-11)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 654,587,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_E1A1DD321AA2](/claim/clm_E1A1DD321AA2.md) | [clm_9D0F451FC952](/claim/clm_9D0F451FC952.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
